adenosine has been researched along with Multiple Sclerosis in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (14.29) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 3 (21.43) | 24.3611 |
2020's | 2 (14.29) | 2.80 |
Authors | Studies |
---|---|
Duarte-Silva, E; Hartung, HP; Meuth, SG; Oliveira-Giacomelli, Á; Peixoto, CA; Ulrich, H | 1 |
Li, J; Liang, J; Sheng, W; Wang, T; Wu, X; Ye, F | 1 |
Fang, Z; Huang, Q; Kong, J; Xu, H; Yang, L; Zhang, J | 1 |
Khalid, R | 1 |
Jadidi-Niaragh, F; Motallebnezhad, M; Safarzadeh, E; Yousefi, M | 1 |
Airas, L; Ifergan, I; Jalkanen, S; Niemelä, J; Prat, A; Yegutkin, GG | 1 |
Bjelobaba, I; Lavrnja, I; Mostarica-Stojkovic, M; Nedeljkovic, N; Pekovic, S; Stojiljkovic, M; Stosic-Grujicic, S | 1 |
Costelloe, L; Fletcher, JM; Kinsella, K; Lonergan, R; Mills, KH; Moran, B; O'Farrelly, C; Tubridy, N | 1 |
CAILLIET, R; LOWRY, ML; MOORE, RW | 1 |
BERMAN, AD | 1 |
Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW | 1 |
Airas, L; Jalkanen, S; Niemelä, J; Yegutkin, G | 1 |
Bitsch, A; Braun, N; Ernst, BP; Metzner, R; Michel, U; Rieckmann, P; Weber, F | 1 |
Geiger, JD; Jiang, Y; Mayne, M; Power, C; Shepel, PN | 1 |
3 review(s) available for adenosine and Multiple Sclerosis
Article | Year |
---|---|
The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis.
Topics: Adenosine; Adenosine Deaminase; Apyrase; Humans; Multiple Sclerosis; Neurodegenerative Diseases; Receptors, Purinergic P1; Signal Transduction | 2022 |
Contributing factors in multiple sclerosis and the female sex bias.
Topics: Adenosine; Adipokines; Environment; Female; Genetic Predisposition to Disease; Hormones; Humans; Immune System; Male; Multiple Sclerosis; Sex Factors | 2014 |
The role of adenosine and adenosine receptors in the immunopathogenesis of multiple sclerosis.
Topics: Adenosine; Animals; Humans; Multiple Sclerosis; Receptors, Purinergic P1 | 2016 |
11 other study(ies) available for adenosine and Multiple Sclerosis
Article | Year |
---|---|
N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis.
Topics: Adenosine; Biomarkers; Humans; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; RNA; Young Adult | 2021 |
Adenosine Promotes the Recovery of Mice from the Cuprizone-Induced Behavioral and Morphological Changes while Effecting on Microglia and Inflammatory Cytokines in the Brain.
Topics: Adenosine; Animals; Behavior, Animal; Brain Chemistry; Cerebral Cortex; Chelating Agents; Cuprizone; Cytokines; Demyelinating Diseases; Dose-Response Relationship, Drug; Gliosis; Hippocampus; Male; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Oligodendroglia; Psychomotor Performance; Schizophrenia | 2018 |
IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier.
Topics: 5'-Nucleotidase; Adenosine; Adult; Astrocytes; Blood-Brain Barrier; Brain; Cell Movement; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Female; Humans; Immunologic Factors; Interferon Type I; Lymphocytes; Male; Middle Aged; Multiple Sclerosis; Recombinant Proteins; Young Adult | 2008 |
Time-course changes in ectonucleotidase activities during experimental autoimmune encephalomyelitis.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Apyrase; Cell Membrane; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Multiple Sclerosis; Rats; Rats, Inbred Strains; Spinal Cord; Time Factors | 2009 |
CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Topics: Adenosine; Adult; Antigens, CD; Apyrase; Cell Communication; Female; Flow Cytometry; Forkhead Transcription Factors; Humans; Interleukin-17; Male; Multiple Sclerosis; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory | 2009 |
Adenosine-5-monophosphate in the treatment of multiple sclerosis.
Topics: Adenosine; Adrenocorticotropic Hormone; Multiple Sclerosis; Nucleotides; Potassium | 1953 |
A METHOD OF EVALUATION IN MULTIPLE SCLEROSIS USING ADENOSINE-5-MONOPHOSPHATE.
Topics: Adenine Nucleotides; Adenosine; Ascorbic Acid; Drug Therapy; Folic Acid; Humans; Multiple Sclerosis; Vitamin B Complex | 1965 |
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Caffeine; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1; Macrophages; Matrix Metalloproteinase 12; Metalloendopeptidases; Mice; Mice, Knockout; Microglia; Multiple Sclerosis; Myelin Sheath; Phenotype; Receptor, Adenosine A1; Recurrence; RNA, Messenger; Severity of Illness Index; Spinal Cord; Up-Regulation | 2004 |
Mechanism of action of IFN-beta in the treatment of multiple sclerosis: a special reference to CD73 and adenosine.
Topics: 5'-Nucleotidase; Adenosine; Cells, Cultured; Endothelial Cells; Humans; Interferon-alpha; Interferon-beta; Multiple Sclerosis; Skin; Time Factors; Up-Regulation | 2007 |
Gene polymorphism at position -308 of the tumor-necrosis-factor-alpha (TNF-alpha) in multiple sclerosis and it's influence on the regulation of TNF-alpha production.
Topics: Adenosine; Adult; Alleles; Cloning, Molecular; Exons; Female; Gene Expression Regulation; Guanine; Humans; Major Histocompatibility Complex; Male; Middle Aged; Multiple Sclerosis; Point Mutation; Polymorphism, Genetic; Promoter Regions, Genetic; Sequence Analysis, DNA; Tumor Necrosis Factor-alpha | 1996 |
Dysregulation of adenosine A1 receptor-mediated cytokine expression in peripheral blood mononuclear cells from multiple sclerosis patients.
Topics: Adenosine; Adult; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Monocytes; Multiple Sclerosis; Receptors, Purinergic P1; Tumor Necrosis Factor-alpha | 1999 |